Abstract
The risks associated with transfusion with blood components have been greatly reduced due to the implementation of innovative strategies for donor selection and testing, as well as safety measures such as universal prestorage leukocyte reduction. However, a variety of residual or unsolved risks, such as severe acute reaction of transfusion-related acute lung injury, transfusion-associated circulatory overload and transfusion-transmitted infections, remain. Patients with hematological disorders are at high risk, since they receive therapeutic interventions frequently requiring transfusion. Thereby, balancing risk and benefit for patients, hematologists should prescribe blood components through evidence-based decision-making, minimize unnecessary transfusions and then conduct safe and error-free transfusion with a standard procedure involving the transfusion process at the bedside.
| Original language | English |
|---|---|
| Pages (from-to) | 2170-2179 |
| Number of pages | 10 |
| Journal | [Rinshō ketsueki] The Japanese journal of clinical hematology |
| Volume | 56 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 2015 Oct 1 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Safer and more appropriate blood transfusion therapy. / Handa, Makoto.
In: [Rinshō ketsueki] The Japanese journal of clinical hematology, Vol. 56, No. 10, 01.10.2015, p. 2170-2179.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Safer and more appropriate blood transfusion therapy
AU - Handa, Makoto
PY - 2015/10/1
Y1 - 2015/10/1
N2 - The risks associated with transfusion with blood components have been greatly reduced due to the implementation of innovative strategies for donor selection and testing, as well as safety measures such as universal prestorage leukocyte reduction. However, a variety of residual or unsolved risks, such as severe acute reaction of transfusion-related acute lung injury, transfusion-associated circulatory overload and transfusion-transmitted infections, remain. Patients with hematological disorders are at high risk, since they receive therapeutic interventions frequently requiring transfusion. Thereby, balancing risk and benefit for patients, hematologists should prescribe blood components through evidence-based decision-making, minimize unnecessary transfusions and then conduct safe and error-free transfusion with a standard procedure involving the transfusion process at the bedside.
AB - The risks associated with transfusion with blood components have been greatly reduced due to the implementation of innovative strategies for donor selection and testing, as well as safety measures such as universal prestorage leukocyte reduction. However, a variety of residual or unsolved risks, such as severe acute reaction of transfusion-related acute lung injury, transfusion-associated circulatory overload and transfusion-transmitted infections, remain. Patients with hematological disorders are at high risk, since they receive therapeutic interventions frequently requiring transfusion. Thereby, balancing risk and benefit for patients, hematologists should prescribe blood components through evidence-based decision-making, minimize unnecessary transfusions and then conduct safe and error-free transfusion with a standard procedure involving the transfusion process at the bedside.
UR - http://www.scopus.com/inward/record.url?scp=84965141929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84965141929&partnerID=8YFLogxK
U2 - 10.11406/rinketsu.56.2170
DO - 10.11406/rinketsu.56.2170
M3 - Article
C2 - 26458457
AN - SCOPUS:84965141929
VL - 56
SP - 2170
EP - 2179
JO - [Rinshō ketsueki] The Japanese journal of clinical hematology
JF - [Rinshō ketsueki] The Japanese journal of clinical hematology
SN - 0485-1439
IS - 10
ER -